June 20, 2018
KEY POINTS The global oncology mAb market is expected to reach around $45 billion by the end of this decade. ...
Categories: NEWLY PUBLISHED, PROGRESSIVE REVIEW
Tags: bio, biosimilar, biosimilar-drug-discovery-review-2018:biosimilar drug discovery review 2018, biosimilar-drug-discovery:biosimilar drug discovery, biosimilar-review-article:biosimilar review article, biosimilar-review:biosimilar review, biosimilars-industry-updates:biosimilars industry updates, biosimilars-review-2018:biosimilars review 2018